1-11 of 11
Jordan Gauthier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Answering the “Doctor, can CAR-T therapy cause cancer?” question in clinic

Clinical Trials & Observations
Rahul Banerjee, Christina Poh, Alexandre V. Hirayama, Jordan Gauthier, Ryan D. Cassaday, Mazyar Shadman, Andrew J. Cowan, Brian G. Till, Damian J. Green, Hans-Peter Kiem, Ajay K. Gopal, David G. Maloney
Journal: Blood Advances
Blood Adv (2024) 8 (4): 895–898.
https://doi.org/10.1182/bloodadvances.2023012336
Published: 2024
Journal Articles

Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma

Alexandre V. Hirayama, Erik L. Kimble, Jocelyn H. Wright, Salvatore Fiorenza, Jordan Gauthier, Jenna M. Voutsinas, Qian Wu, Cecilia C. S. Yeung, Nicolas Gazeau, Barbara S. Pender, Delaney R. Kirchmeier, Aiko Torkelson, Abigail N. Chutnik, Ryan D. Cassaday, Aude G. Chapuis, Damian J. Green, Hans-Peter Kiem, Filippo Milano, Mazyar Shadman, Brian G. Till, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2024) 8 (2): 453–467.
https://doi.org/10.1182/bloodadvances.2023011287
Published: 2024
Includes: Supplemental data
Journal Articles

Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL

Clinical Trials & Observations
Emily C. Liang, Aya Albittar, Jennifer J. Huang, Alexandre V. Hirayama, Erik L. Kimble, Andrew J. Portuguese, Aude Chapuis, Mazyar Shadman, Brian G. Till, Ryan D. Cassaday, Filippo Milano, Hans-Peter Kiem, Stanley R. Riddell, Cameron J. Turtle, David G. Maloney, Jordan Gauthier
Journal: Blood Advances
Blood Adv (2023) 7 (22): 6990–7005.
https://doi.org/10.1182/bloodadvances.2023011399
Published: 2023
Includes: Supplemental data
Journal Articles

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Geoffrey Shouse, Andy Kaempf, Max J. Gordon, Andy Artz, David Yashar, Audrey M. Sigmund, Gordon Smilnak, Steven M. Bair, Agrima Mian, Lindsey A. Fitzgerald, Amneet Bajwa, Samantha Jaglowski, Neil Bailey, Mazyar Shadman, Krish Patel, Deborah M. Stephens, Manali Kamdar, Brian T. Hill, Jordan Gauthier, Reem Karmali, Loretta J. Nastoupil, Adam S. Kittai, Alexey V. Danilov
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3516–3529.
https://doi.org/10.1182/bloodadvances.2022009309
Published: 2023
Includes: Supplemental data
Journal Articles

A novel polymer-conjugated human IL-15 improves efficacy of CD19-targeted CAR T-cell immunotherapy

Alexandre V. Hirayama, Cassie K. Chou, Takahiro Miyazaki, Rachel N. Steinmetz, Henna A. Di, Simon P. Fraessle, Jordan Gauthier, Salvatore Fiorenza, Reed M. Hawkins, Willem W. Overwijk, Stanley R. Riddell, Mario Q. Marcondes, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2479–2493.
https://doi.org/10.1182/bloodadvances.2022008697
Published: 2023
Includes: Supplemental data
Journal Articles

Humoral and cellular responses to SARS-CoV-2 vaccines before and after chimeric antigen receptor–modified T-cell therapy

Clinical Trials & Observations
Michael A. Gonzalez, Atif M. Bhatti, Kristin Fitzpatrick, Jim Boonyaratanakornkit, Meei-Li Huang, Victoria L. Campbell, Jessica Hecht, Sarah Ibrahimi, Shera N. Wanner, Damian J. Green, David G. Maloney, Jordan Gauthier, Andrew J. Cowan, Alexander L. Greninger, Elizabeth M. Krantz, David M. Koelle, Joshua A. Hill
Journal: Blood Advances
Blood Adv (2023) 7 (9): 1849–1853.
https://doi.org/10.1182/bloodadvances.2022008338
Published: 2023
Includes: Supplemental data
Journal Articles

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy

Clinical Trials & Observations
Krishna R. Juluri, Qian Vicky Wu, Jenna Voutsinas, Jue Hou, Alexandre V. Hirayama, Erin Mullane, Nancy Miles, David G. Maloney, Cameron J. Turtle, Merav Bar, Jordan Gauthier
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2055–2068.
https://doi.org/10.1182/bloodadvances.2020004142
Published: 2022
Includes: Supplemental data
Journal Articles

Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis

Mehdi Hamadani, Ajay K. Gopal, Marcelo Pasquini, Soyoung Kim, Xianmiao Qiu, Sairah Ahmed, Aleksandr Lazaryan, Vijaya Raj Bhatt, Andrew Daly, Premal Lulla, Stefan Ciurea, Jordan Gauthier, Vaibhav Agrawal, Natalie S. Grover, Lazaros Lekakis, Dipenkumar Modi, Parastoo B. Dahi, Megan M. Herr, P. Connor Johnson, Hamza Hashmi, Peiman Hematti, Frederick L. Locke
Journal: Blood Advances
Blood Adv (2022) 6 (2): 486–494.
https://doi.org/10.1182/bloodadvances.2021005788
Published: 2022
Includes: Supplemental data
Journal Articles

Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy

Clinical Trials & Observations
Victor A. Chow, Ajay K. Gopal, Jordan Gauthier, Yolanda D. Tseng, Cameron J. Turtle, David G. Maloney, Mazyar Shadman
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4869–4872.
https://doi.org/10.1182/bloodadvances.2020002292
Published: 2020
Journal Articles

Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy

Mazyar Shadman, Jordan Gauthier, Kevin A. Hay, Jenna M. Voutsinas, Filippo Milano, Ang Li, Alexandre V. Hirayama, Mohamed L. Sorror, Sindhu Cherian, Xueyan Chen, Ryan D. Cassaday, Brian G. Till, Ajay K. Gopal, Brenda M. Sandmaier, David G. Maloney, Cameron J. Turtle
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3062–3069.
https://doi.org/10.1182/bloodadvances.2019000593
Published: 2019
Journal Articles

Successful treatment with fingolimod of graft-versus-host disease of the central nervous system

Clinical Trials & Observations
Jordan Gauthier, Patrick Vermersch, Paul Chauvet, Pauline Varlet, Valérie Coiteux, Leonardo Magro, Ibrahim Yakoub-Agha
Journal: Blood Advances
Blood Adv (2018) 2 (1): 10–13.
https://doi.org/10.1182/bloodadvances.2017011478
Published: 2018